Search
Patexia Research
Case number 1:22-cv-01386

ACADIA Pharmaceuticals Inc. v. Zydus Pharmaceuticals (USA) Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Apr 5, 2023 16 Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 04/05/2023) (3)
Apr 4, 2023 15 STIPULATION of Dismissal without prejudice pursuant to Fed. R. Civ. P. 41(a) by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 04/04/2023) (2)
Feb 2, 2023 14 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Main Document) (2)
Feb 2, 2023 14 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of Michael J. Gaertner) (1)
Feb 2, 2023 14 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of James T. Peterka) (1)
Feb 2, 2023 14 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of Timothy F. Peterson) (1)
Feb 2, 2023 14 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of August M. Melcher) (1)
Feb 2, 2023 14 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of Amy Lange) (1)
Jan 30, 2023 11 ANSWER to 1 Complaint Affirmative Defenses by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 01/30/2023) (17)
Jan 30, 2023 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) (Entered: 01/30/2023) (2)
Jan 30, 2023 13 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Zydus Lifesciences Limited. (Bilson, David) (Entered: 01/30/2023) (2)
Dec 19, 2022 10 NOTICE requesting Clerk to remove Aubrey J. Morin as co-counsel. Reason for request: No longer with the firm of Saul Ewing LLP. (Streifthau-Livizos, Michelle) (Entered: 12/19/2022) (1)
Dec 9, 2022 9 STIPULATION TO EXTEND TIME Defendants to respond to complaint to January 30, 2023 - filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 12/09/2022) (2)
Dec 2, 2022 8 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Scott F. Peachman, Rebecca A. Hilgar and Felix A. Eyzaguirre - filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 12/02/2022) (7)
Nov 8, 2022 6 WAIVER OF SERVICE returned executed by ACADIA Pharmaceuticals Inc.: For Zydus Lifesciences Limited waiver sent on 11/1/2022, answer due 1/3/2023. (Streifthau-Livizos, Michelle) (Entered: 11/08/2022) (1)
Nov 8, 2022 7 WAIVER OF SERVICE returned executed by ACADIA Pharmaceuticals Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 11/1/2022, answer due 1/3/2023. (Streifthau-Livizos, Michelle) (Entered: 11/08/2022) (1)
Oct 24, 2022 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 10/24/2022) (2)
Oct 21, 2022 1 Complaint* (1)
Oct 21, 2022 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 10/24/2022) (3)
Oct 21, 2022 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached. (mpb) (Entered: 10/24/2022) (2)
Oct 21, 2022 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,452,721. (mpb) (Entered: 10/24/2022) (1)
Menu